TNFα对膀胱癌细胞株NF-κB信号通路分子表达及细胞增殖水平的影响

来源 :第十四届全国肿瘤生物治疗大会 | 被引量 : 0次 | 上传用户:leneyao
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  目的:研究肿瘤坏死因子α(TNF-α)诱导下,膀胱癌细胞中NF-κB通路分子的表达变化及其对细胞增殖水平的影响。方法:50 ng/ml TNF-α分别处理T24、5637膀胱癌细胞株,应用实时荧光定量PCR检测TNFα处理后膀胱癌T24、5637细胞株NF-κB信号通路中RelA、RelB基因表达的改变,CCK-8 (cell counting kit-8)法检测处理后细胞增殖活性的变化情况。
其他文献
目的:研究负载阿霉素(doxorubicin,DOX)的透明质酸修饰还原敏感纳米粒子HA-Lys-LA对乳腺癌细胞株MDA-MB231的靶向性及其抗肿瘤效果。方法:通过流式细胞术检测人乳腺癌细胞株MDA-MB231细胞表面CD44分子的表达,以及检测对负载DOX的透明质酸修饰还原敏感纳米粒子HA-Lys-LA (DOX-NPs)的摄取情况;利用CCK-8试剂盒检测DOX-NPs对乳腺癌细胞株MDA
背景:宫颈癌是世界上女性最常见的三大恶性肿瘤之一,发展中国家女性第二大死亡原因.如何对宫颈癌进行有效诊断和寻找新的治疗靶点值得深入探讨.LGR5是近年新发现的肿瘤干细胞标志物,与肿瘤的发生发展关系密切.本文通过体内外实验阐述了LGR5分子在宫颈癌组织中的表达规律及RSPO1/LGR5途径对宫颈癌肿瘤细胞生物学行为的影响,这有助于靶向肿瘤干细胞进行宫颈癌的诊断和治疗.
EB病毒目前已经证实与多种肿瘤发生密切相关,包括伯基特淋巴瘤、霍奇金淋巴瘤、鼻咽癌、胃癌以及淋巴细胞增生症。虽然EB病毒特异的CTL细胞在治疗EB病毒相关的淋巴细胞增生症中取得很好的疗效,但是由于EB病毒相关肿瘤下调EB病毒相关蛋白,从而使得EB病毒特异的CTL细胞治疗EB病毒相关肿瘤疗效欠佳。
Gemcitabine is a therapeutic agent for advanced breast cancer with high antitumor activity and relatively mild toxicity.Several clinical trials revealed that estrogen receptor (ER) status had relevanc
Tumor-induced, myeloid-derived suppressor cells (MDSCs)-mediated immune dysfunction is an important mechanism that leads to tumor immune escape and the inefficacy of cancer immunotherapy.Importantly,t
Toll-like receptor (TLR) 4-mediated signaling has been shown to be important to tumor cell survival,invasion and metastasis in a variety of cancers.The present study aimed to explore the role and down
Increased expression of galectin-1 (Gal-1) in carcinoma-associated fibroblasts (CAFs) has been reported to correlate with progression and prognosis in many cancers.However, rarely have reports sought
Metastasis is responsible for more than 90% of the mortality observed among patients with breast cancer.Human phosphatidylethanolamine-binding protein 4 (hPEBP4) is a novel member of the PEBP family a
Objective: The epidermal growth factor receptor pathway substrate 8 (EPS8) plays a critical role in the proliferation, progression and metastasis of solid as well as hematological cancers, and thus co
BACKGROUND:Non-Hodgkins Lymphoma is one of the highly invasion tumor in hematology, with the amazing growth rate and complex pathology characteristics.More than 50%-60% patients with aggressive B-cell